Organizational Disclosure

Below is a breakdown of industry contribution towards the consolidated revenue of the Academy (American Academy of Neurology and American Academy of Neurology Institute). Industry includes for-profit entities that develop, produce, market, or distribute drugs, devices, services, or therapies used to diagnose, treat, monitor, manage, and alleviate health conditions (e.g., pharmaceutical and medical device/software manufacturers and other for-profit health services/product providers). Industry does not include non-profit entities, entities outside of the healthcare sector, or entities through which physicians provide clinical services directly to patients (e.g., hospitals, medical centers, publishers, foundations, recruiters, insurance providers).


  • Total Industry Revenue: $7,543,824
  • Percentage of Total Academy Revenue: 17%
  • Educational Grants: $551,916
  • Sponsorship: $3,725,358
  • Exhibit Space: $2,516,550
  • Charitable Contributions:  
  • Industry Roundtable Membership Dues : $750,000

Total contribution by company in 2015 (Greater than $100K):

  • Novartis Pharmaceuticals
  • Biogen Idec
  • Sanofi Genzyme
  • TEVA Neuroscience, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Allergan, Inc.
  • Lundbeck Inc.
  • Genentech
  • ACADIA Pharmaceuticals Inc.
  • FORUM Pharmaceuticals Inc.
  • Mallinckrodt Pharmaceuticals, Inc.
  • Medtronic, Inc.
  • Mylan
  • Eisai Inc.
  • Lilly USA, LLC
  • Supernus Pharmaceuticals, Inc.
  • Upsher-Smith

View the Principles Governing Academy Relationships with External Sources of Support.

View the Council of Medical Specialty Societies Code for Interactions with Companies.

Related Content


Forgot password?